SCROLL DOWN
Diabetes is a chronic metabolic disorder.
If abnormal blood glucose levels are not detected and managed early, they can progress to diabetes and lead to severe complications such as cardiovascular disease, kidney disease, and nerve damage.
Global Diabetes Status
590 million people worldwide live with type 2 diabetes. Global healthcare expenditure attributable to diabetes has surpassed $1 trillion annually, placing it alongside cancer as one of the most economically burdensome diseases.
Diabetes Risk Population
The global population of overweight and obese individuals has reached approximately 2.89 billion - nearly one in two adults worldwide. In addition, the global prediabetes population has already reached 1.12 billion.
Diabetes Rising in Youth
The number of children and adolescents diagnosed with diabetes is rising sharply worldwide, with type 2 diabetes — once considered an adult-onset disease — being diagnosed with increasing frequency in younger populations.
PRODUCTS 
Salivary glucose monitoring system
Tech Overview
D-SaLife® is a salivary glucose monitoring system that measures glucose levels without blood sampling, allowing users to check their glucose status comfortably without needles.
Detecting glucose in saliva presents a significant technical challenge, as salivary glucose concentrations are far lower than those found in blood. To address this challenges, D-SaLife® integrates three core technologies: (1) A high-sensitivity salivary glucose sensor, (2) Advanced semiconductor design, and (3) An AI-powered electrochemical signal analysis algorithm — enabling precise and reliable glucose measurement from saliva.
The system consists of an integrated platform comprising a Meter, Strip and Saliva Collector. The technology is backed by clinical studies conducted in collaboration with leading university hospitals in Korea, with hundreds of clinical data points validating its accuracy and performance.
Looking ahead, D-SaLife® is designed to evolve beyond glucose monitoring into a comprehensive saliva-based diagnostic platform — capable of detecting multiple biomarkers, including those associated with cancer.
Key Features
1Blood-Free Glucose Monitoring
Measure glucose levels using saliva instead of blood, with no needles or finger-pricks requiredainless testing Eliminates risk of infection
2 No Pain, No Fear
Suitable for all age groups— including children, adolescents, and the elderly — without the pain or Fear associated with needles or blood sampling
3Affordable & Accessible
Enabling regular glucose monitoring at an affordable cost, making it accessible to a broader population
Diabetes is a chronic metabolic disorder. If abnormal blood glucose levels are not detected
and managed early, they can progress to diabetes and lead to severe complications
such as cardiovascular disease, kidney disease, and nerve damage.
Global Diabetes Status
590 million people worldwide live with type 2 diabetes. Global healthcare expenditure attributable to diabetes has surpassed $1 trillion annually, placing it alongside cancer as one of the most economically burdensome diseases.
Diabetes Risk Population
The global population of overweight and obese individuals has reached approximately 2.89 billion - nearly one in two adults worldwide. In addition, the global prediabetes population has already reached 1.12 billion.
Diabetes Rising in Youth
The number of children and adolescents diagnosed with diabetes is rising sharply worldwide, with type 2 diabetes — once considered an adult-onset disease — being diagnosed with increasing frequency in younger populations.
PRODUCTS
Salivary glucose monitoring system
Tech Overview
D-SaLife® is a salivary glucose monitoring system that measures glucose levels without blood sampling, allowing users to check their glucose status comfortably without needles.
Detecting glucose in saliva presents a significant technical challenge, as salivary glucose concentrations are far lower than those found in blood. To address this challenges, D-SaLife® integrates three core technologies: (1) A high-sensitivity salivary glucose sensor, (2) Advanced semiconductor design, and (3) An AI-powered electrochemical signal analysis algorithm — enabling precise and reliable glucose measurement from saliva.
The system consists of an integrated platform comprising a Meter, Strip and Saliva Collector. The technology is backed by clinical studies conducted in collaboration with leading university hospitals in Korea, with hundreds of clinical data points validating its accuracy and performance.
Looking ahead, D-SaLife® is designed to evolve beyond glucose monitoring into a comprehensive saliva-based diagnostic platform — capable of detecting multiple biomarkers, including those associated with cancer.
Key Features
1 Blood-Free Glucose Monitoring
Measure glucose levels using saliva instead of blood,
with no needles or finger-pricks required
2 No Pain, No Fear
Suitable for all age groups— including children, adolescents, and the elderly —
without the pain or Fear associated with needles or blood sampling
3 Affordable & Accessible
Enabling regular glucose monitoring at an affordable cost,
making it accessible to a broader population
Company Name : Dongwoon Anatech Co., Ltd.
CEO : Kim, Dong Cheol
Address : 13F, Seocho Pyeonghwa Building, 22 Banpo-daero, Seocho-gu, Seoul, Republic of Korea
Tel : +82-2-3465-8765
Fax : +82-2-3465-8766
E-Mail : dw_sales@dwanatech.com
Copyright © DONGWOON ANATECH CO., LTD.
All Rights Reserved.
Company Name : Dongwoon Anatech Co., Ltd. | CEO : Kim, Dong Cheol
Address : 13F, Seocho Pyeonghwa Building, 22 Banpo-daero, Seocho-gu, Seoul, Republic of Korea
Tel : +82-2-3465-8765 | Fax : +82-2-3465-8766 | E-Mail : dw_sales@dwanatech.com
Copyright © DONGWOON ANATECH CO., LTD. All Rights Reserved.
